Ferrum Lek
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ferrum Lek, covering 2021-07-12 to 2021-07-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia. [Phase 3]